Evidence map›Paper›PMID 42641171›Full record

ArticleCancer research communications2026

Community-Based Hereditary Breast and Ovarian Cancer Family History Assessment and Genetic Testing among Spanish-Speaking Hispanic/Latina Women in California.

Daisy M Montoya, Amanda F Corpuz, Karla E Gonzalez, Kaylee Santos, Alyssa Reed, Julie H T Dang, Helen K Chew, Guadalupe Polanco-Echeverry, Lizeth I Tamayo, Miriam T Hernandez and 6 more

Abstract read
In one paragraph

Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daisy M Montoya *University of California, Davis , Davis, California.ORCID 0009-0007-1697-2639
Amanda F Corpuz *University of California, Davis , Davis, California.ORCID 0009-0002-8738-7115
Karla E GonzalezUniversity of California, Davis , Davis, California.ORCID 0009-0009-6682-0507
Kaylee SantosUniversity of California, Davis , Davis, California.ORCID 0009-0003-9693-3023
Alyssa ReedUniversity of California, Davis , Davis, California.ORCID 0000-0001-6912-6144
Julie H T DangUniversity of California, Davis , Davis, California.ORCID 0000-0002-0597-7457
Helen K ChewUniversity of California, Davis , Davis, California.ORCID 0009-0009-8372-1180
Guadalupe Polanco-EcheverryUniversity of California, Davis , Davis, California.ORCID 0000-0002-3373-628X
Lizeth I TamayoDepartment of Public Health Sciences, University of Chicago, Chicago, Illinois.ORCID 0000-0002-2417-3331
Miriam T HernandezVisión y Compromiso, Los Angeles, California.ORCID 0009-0003-7567-8086
Alejandra MartinezPromoters for Better Health, Pomona, California.
Elad ZivUniversity of California, San Francisco , San Francisco, California.ORCID 0000-0002-2324-2884
Susan L NeuhausenDepartment of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, California.ORCID 0000-0001-5053-0390
Luis G Carvajal-CarmonaUniversity of California, Davis , Davis, California.ORCID 0000-0001-7129-2918
Ysabel DuronThe Latino Cancer Institute, San Jose, California.ORCID 0000-0003-4926-2805
Laura FejermanUniversity of California, Davis , Davis, California.ORCID 0000-0003-3179-1151

Funding

California Precision Medicine Initiative OPR18111Comprehensive Cancer Center, University of California, Davis (UC Davis Comprehensive Cancer Center)Placer Breast Cancer Endowed ChairThe Heart, BrEast and BrAin HeaLth Equity Research (HEAL-HER) Program
6 · The paper itself

Abstract

Breast cancer is the most common cancer among women in the United States and the leading cause of cancer incidence and mortality among Hispanic/Latina (H/L) women. For women with a genetic predisposition to hereditary breast and ovarian cancer (HBOC), genetic counseling has been shown to aid in the decision-making process and engagement in risk-reducing strategies for cancer prevention and early detection. However, H/L women are less likely to receive genetic testing and undergo genetic counseling than non-Hispanic White women. We developed a promotores-led virtual HBOC outreach, education, and risk assessment program [Tu Historia Cuenta (THC)] for Spanish-speaking H/L women in California. In this study, we describe genetic testing uptake, testing results, and participants' experiences. Participants (N = 1,286) responded to a demographic and HBOC family history survey. Those identified as high risk based on the family history survey were offered free genetic testing with a hereditary cancer panel. Of the 111 women identified as high risk, 18 had been previously tested, and 33 received genetic testing through THC, resulting in a 35.5% completion rate for those offered testing. Among the 51 women with test results, 6 had a positive result, 3 were carriers of a variant of unknown significance, 38 had a negative result, and 4 participants tested before recruitment did not know their results. Participants who tested through THC indicated satisfaction with the genetic testing process. These findings underscore the importance of simplifying access and exploring additional factors influencing H/L women's decision to receive testing beyond previously established cost, awareness, and knowledge barriers. SIGNIFICANCE: Utilization of genetic testing and genetic counseling among H/L women in the United States remains limited. The promotores-led THC is one of the first community-based outreach programs for Spanish-speaking H/L women outside of a healthcare setting. Overcoming barriers such as language, cost, and knowledge, we identified additional obstacles such as testing kit activation and fear of future costs.

Indexed as

Breast NeoplasmsGenetic TestingHispanic or LatinoOvarian NeoplasmsAdultAgedCaliforniaFemaleGenetic CounselingGenetic Predisposition to DiseaseHumansMiddle AgedRisk Assessment

Identifiers

PMID42641171
PMCPMC13561150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.